Zepatier Drug Insight 2019

A comprehensive product overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report

Press Release

“Zepatier Drug Insight 2019” report by DelveInsight provides comprehensive information of the drug, Zepatier. It includes Zepatier`s overview, mechanism, clinical trials, regulatory milestones, deals & partnerships. It further provides Zepatier`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted sales of Zepatier till 2021. The report also throws light on Zepatier`s market competition and emerging therapies in the same space as Zepatier. A SWOT analysis of Zepatier is also featured. * Depending on information availability

Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
• A comprehensive product overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
• Patent information around Zepatier in United States (US) and Europe (EU) has been highlighted
• API manufacturers for Zepatier in United States, Europe, China and India
• The report contains historical and forecasted sales for Zepatier till 2021
• Comprehensive coverage of the emerging therapies (Phase III) in the space where Zepatier operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
• The report also features the SWOT analysis of Zepatier

Reasons to Buy
• Establish a comprehensive understanding of the drug, Zepatier
• Access to Zepatier`s API manufacturers details to devise API procurement strategy for generic development
• Plan developmental timelines around Zepatier`s patents for the major markets- US and EU
• Understand Zepatier`s current and future growth through its historical and forecasted sales
• Identify and understand the current in-market competitors for Zepatier
• Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
• Identify and plan ahead for prospective emerging players and their products operating in the same space as Zepatier
• Identify opportunities in the same area as Zepatier with DelveInsight`s SWOT analysis

Request for sample pages

Table of contents

1. Report Introduction
2. Zepatier – Overview
• Product Description
• Route of Synthesis
• Mechanism of Action
• Pharmacology
• Pharmacodynamics
• Pharmacokinetics
• Adverse Reactions
• Clinical Trials
• Regulatory Milestones
• Product Development Activities
3. Global API Manufacturers
• United States
• Europe
• China
• India
4. Product Details
• United States
• Europe
5. Zepatier Global Sales Assessment
• Historical Global Sales
• Forecasted Global Sales
6. Patent Details
7. Market Competition
8. Emerging Therapies
8.1. Drug name: Company name
• Product Description
• Research & Development
• Product Development Activities
Other product profiles in the detailed reportÂ…..
9. SWOT Analysis
Consulting Services
About DelveInsight
Contact Us


Related Articles